Research Comparison

Selank vs Semax

Side-by-side research comparison of Selank and Semax across our PubMed, ClinicalTrials.gov, and EuropePMC corpus. 3 head-to-head studies plus 74 on Selank and 74 on Semax.

3 head-to-head · 74 on Selank · 74 on Semax

At a glance

  Selank Semax
Drug class nootropic, anxiolytic nootropic
Studies in corpus 74 74
Highest evidence tier rct rct
Evidence tier mix other · 23 rct · 2 preclinical animal · 38 in vitro · 6 review · 1 cohort · 1 preclinical animal · 51 other · 10 review · 2 in vitro · 8 rct · 1
Studies with explicit sample size 5 3
Head-to-head studies in corpus 3

Lab evidence, head to head

Beyond the literature: here's what third-party Certificate-of-Analysis records (Janoshik, BCC, Auxlabs) say about real Selank and Semax batches we've tested. Aggregate, public data — cross-reference against the studies below.

Selank

We tested 1316 Selank batches across 599 manufacturers, 99.66% avg purity.

1316
Batches tested
599
Manufacturers
99.66%
Avg purity
1
Failed <90%
34
Underdosed >10%
All Selank COA records →

Semax

We tested 1424 Semax batches across 653 manufacturers, 99.42% avg purity.

1424
Batches tested
653
Manufacturers
99.42%
Avg purity
24
Underdosed >10%
All Semax COA records →

We hold deeper lab coverage on Semax (1424 batches tested). Selank edges ahead on average measured purity (99.66% vs 99.42%) — a narrow gap; weigh it against failed-batch and underdose counts above.

Head-to-head studies

Studies in our corpus that mention both Selank and Semax — the gold-standard direct comparison evidence.

Top studies per peptide

Vendor data

Looking for vendor-level purity, endotoxin, and HPLC data on Selank or Semax? TitrateLab tracks Certificate-of-Analysis records from the major peptide labs (Janoshik, BCC, Auxlabs) alongside the research above. Cross-reference vendor batches against the studies on this page.

Explore each peptide